membranes generally, as well as in Ignicoccus.
Indeed, the cell structure of this archaeon is unlike that of any known bacterium but strikingly similar to that of eukaryotes. These differences make I. hospitalis a prime candidate for being a eukaryotic ancestor, one that could provide ATP and other molecules to an incorporated symbiont without the need for any interactions between the cytoplasm of either it or the host.
"This work also sheds light on the interaction between I. hospitalis ('the friendly fire sphere') and its companion archaeon, Nanoarchaeum equitans ('the riding dwarf'), which has the smallest archaeal genome known and lacks nearly all metabolic and biosynthetic genes," says Ulf Kü per, the research team's lead scientist. N. equitans grows exclusively on the surface of I. hospitalis, and the central question is how energy is transferred from host to rider. "Having ATP formation in the periplasm of I. hospitalis avoids the complex import of energy across three membranes into N. equitans," Kü per says.
The need for easy energy transfer from I. hospitalis to the nanoarchaeon may even have driven the evolution of its novel cellular architecture. "Archaea are full of surprises, as would be expected from organisms with such extreme survival talents," says Schaechter, who believes that many more surprises are in store. One big problem with EpiSims and others like it is that they are programmed to follow normal behaviors of individuals, Fefferman says. "EpiSims wasn't created to account for unusual behavior." Although that model provides "very important insights," it falls short in dealing with "unpredictability" and other situations for which there are "no good algorithms."
Marcia Stone
However, some computer games are designed to let individuals react to such situations, according to Yasmin Kafai of the University of Pennsylvania Graduate School of Education in Philadelphia. "When we participate in a virtual epidemic outbreak, we experience . . . through our avatars what it's like to get infected," she says. "The opportunity to become . . . an observer and a participant of how an epidemic plays out on multiple levels, the community, social interactions, and on your own decisions provides an unprecedented learning opportunity."
Consider this scenario. Another game, WOW, becomes progressively more challenging, and players advance as their gaming skills improve. WOW programmers added an infectious disease outbreak called Corrupted Blood to an advanced level. Some players abandoned the disease level, moving their avatars back to less-complicated levels. However, in some cases, moving infected avatars to lower levels also spread the disease. Moreover, infected avatar pets also began spreading the disease throughout the levels, simulating a zoonosis.
In the cyber-world, epidemics spark panic, curiosity, altruism, and even mingling of infected and uninfected avatars, creating more chaos. "People are not always rational in their decision-making and behaviors," Kafai says. "It's perhaps not just the unpredictability that needs to be factored into models but also the ingenuity of unexpected behaviors that players display when online." "As not all epidemics are useful for epidemiology, not all epidemiological questions can or should be explored using virtual worlds," Fefferman cautions. "I'm fond of the analogy of drug trials in mice: no one believes that a drug trial in a rodent will provide all the answers about the mechanisms and pathways and effects that a compound will cause in a human, but it's a very good model system."
Brian Hoyle
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Microbes in Cave Appear To Be Source of Rock Varnish
Some microorganisms not only coat rocks with a thin black veneer, they do so much faster than earlier estimates indicate, according to geomicrobiologist Michael Spilde from the Institute of Meteoritics at the University of New Mexico, Albuquerque, N.M., and his collaborators. Ther results were presented last year during the Geological Society of America (GSA) annual meeting in Portland, Ore. The microbes are actively making rock varnish in caves. Although no one claims to observe comparable biotic processes in desert settings, the varnish in caves appears the same as varnish found on desert rocks, suggesting it, too, has biologic origins. The humidity in caves may help to account for the relative speed of microbial varnish production there, according to Spilde. Based on manganese-oxidizing microbes that are actively producing rock varnish in Fort Stanton Cave in New Mexico, growth greatly exceeds the 40 m per 1,000 years rate that others in this field consider standard.
Puzzlement over rock varnish dates back at least to naturalist Alexander von Humboldt. Considered the first geographer, he puzzled over the dark coatings that he observed on rocks and boulders while exploring South America during the early 1800s.
Two centuries later, geomicrobiologists Tanzhuo Liu and Wallace S. Broecker from the Lamont-Doherty Earth Observatory of Columbia University at Palisades, N.Y., did not say how rock varnish is made but concluded that it accumulates ever so slowly. Based on a set of 42 rock varnishes from western U.S. deserts, they reported in 2000 that that rock varnish grows at a rate of 1-40 m per 1,000 years, making it the slowest known accumulating sedimentary deposit.
However, if Spilde and his collaborators are correct, cave varnish grows very quickly. For instance, in places where they removed samples a year ago, some regrowth has occurred. That comparative speed suggests that the availability of water or water vapor could accelerate growth of varnish in caves compared to rock varnish in desert settings.
"The walls are coated with black manganese oxide deposits that look so much like desert varnish that you would think you were on the desert surface instead of hundreds of meters underground," Spilde says, referring to Fort Stanton Cave. "Some of the cave varnish is smooth and shiny just like varnish in the Mojave Desert, and contains micro-
Federal Court: Thimerosal in Vaccines Not a Cause of Autism
The U.S. Court of Federal Claims in Washington, D.C., ruled in three cases last March that thimerosal, a preservative used in vaccines, was not a cause of autism in children who received those vaccines. Those three cases were identified as representative prototypes for the approximately 5,000 unresolved cases in which parents filed lawsuits making claims against vaccines with mercury-containing thimerosal as a preservative. The rulings are considered part of the "largest omnibus proceeding in the history of the Vaccine Act," a 1986 federal statute that establishes procedures for filing claims for alleged damages from vaccinations. "Having failed to satisfy their burden of proof under the articulated legal standard, petitioners cannot prevail on their claim of vaccine-related causation," the court's March ruling states. Details are available at http://www.uscfc.uscourts.gov/node/5026/.
